News Alert: FDA approves 1st new type of antidepressant in decades, a nasal spray that could help those who don't respond to other treatments

The Food and Drug Administration approved the drug for people with major depressive disorder that does not respond to other treatments, a group that includes about 5 million people in the United States. The drug, called esketamine, works in a new way in the brain and has been eagerly anticipated by psychiatrists and patient groups.

Democracy Dies in Darkness     News Alert Mar 5, 7:48 PM     FDA approves 1st new type of antidepressant in decades, a nasal spray that could help those who don't respond to other treatments The Food and Drug Administration approved the drug for people with major depressive disorder that does not respond to other treatments, a group that includes about 5 million people in the United States. The drug, called esketamine, works in a new way in the brain and has been eagerly anticipated by psychiatrists and patient groups. Read more » Advertisement You received this email because you signed up for news alerts from The Washington Post. Manage my newsletters and alerts | Unsubscribe Privacy Policy | Help ©2019 The Washington Post, 1301 K St NW, Washington DC 20071